Ragnar Dahle

1.0k total citations
4 papers, 739 citations indexed

About

Ragnar Dahle is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Ragnar Dahle has authored 4 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 1 paper in Molecular Biology. Recurrent topics in Ragnar Dahle's work include Asthma and respiratory diseases (3 papers), Respiratory and Cough-Related Research (2 papers) and Cancer therapeutics and mechanisms (1 paper). Ragnar Dahle is often cited by papers focused on Asthma and respiratory diseases (3 papers), Respiratory and Cough-Related Research (2 papers) and Cancer therapeutics and mechanisms (1 paper). Ragnar Dahle collaborates with scholars based in Norway, Croatia and Denmark. Ragnar Dahle's co-authors include Pier Luigi Paggiaro, Lucy Frith, John Efthimiou, Kate Hollingworth, I Bakran, Roy M. Bremnes, Jan Vilsvik, Einar Hannisdal, Steinar Aamdal and Ulf Aasebø and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Allergy.

In The Last Decade

Ragnar Dahle

4 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ragnar Dahle Norway 4 482 326 291 270 131 4 739
Dawn Midwinter United Kingdom 12 579 1.2× 94 0.3× 43 0.1× 271 1.0× 57 0.4× 32 668
N.J.J. Schlösser Netherlands 8 479 1.0× 155 0.5× 74 0.3× 284 1.1× 51 0.4× 16 593
Alexa Núñez Spain 11 243 0.5× 57 0.2× 31 0.1× 145 0.5× 51 0.4× 40 375
Annamaria Vinciguerra Italy 13 373 0.8× 119 0.4× 54 0.2× 247 0.9× 18 0.1× 45 618
Karel Hejduk Czechia 12 324 0.7× 50 0.2× 27 0.1× 165 0.6× 31 0.2× 57 429
Anna Tomiak Canada 10 184 0.4× 259 0.8× 78 0.3× 44 0.2× 57 0.4× 17 404
Peter D’Andrea United States 16 1.2k 2.6× 47 0.1× 24 0.1× 996 3.7× 19 0.1× 55 1.4k
Fredrik Wiklund Sweden 9 528 1.1× 190 0.6× 16 0.1× 344 1.3× 38 0.3× 20 655
W. Bakker Netherlands 12 261 0.5× 172 0.5× 121 0.4× 18 0.1× 71 0.5× 18 435
Yasuhiko Miura Japan 17 180 0.4× 235 0.7× 96 0.3× 37 0.1× 58 0.4× 48 642

Countries citing papers authored by Ragnar Dahle

Since Specialization
Citations

This map shows the geographic impact of Ragnar Dahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragnar Dahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragnar Dahle more than expected).

Fields of papers citing papers by Ragnar Dahle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ragnar Dahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragnar Dahle. The network helps show where Ragnar Dahle may publish in the future.

Co-authorship network of co-authors of Ragnar Dahle

This figure shows the co-authorship network connecting the top 25 collaborators of Ragnar Dahle. A scholar is included among the top collaborators of Ragnar Dahle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ragnar Dahle. Ragnar Dahle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Søes‐Petersen, Ulrik, et al.. (2010). Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted ‘real life’ setting. The Clinical Respiratory Journal. 5(3). 173–182. 15 indexed citations
2.
Sundstrøm, Stein, Roy M. Bremnes, Stein Kaasa, et al.. (2002). Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up. Journal of Clinical Oncology. 20(24). 4665–4672. 345 indexed citations
3.
Paggiaro, Pier Luigi, Ragnar Dahle, I Bakran, et al.. (1998). Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. The Lancet. 351(9105). 773–780. 372 indexed citations
4.
Dahle, Ragnar, et al.. (1988). Effects of withdrawal of sustained‐release theophylline in patients with chronic obstructive lung disease. Allergy. 43(6). 411–414. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026